2.21

3.76% 0.08

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $2.21, with a volume of 226.44K. It is up +3.76% in the last 24 hours and up +9.41% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$2.13

Open:

$2.13

24h Volume:

226.44K

Relative Volume:

0.54

Market Cap:

$190.06M

Revenue:

$25.14M

Net Income/Loss:

$-21.57M

P/E Ratio:

-8.1852

EPS:

-0.27

Net Cash Flow:

$-12.23M

1W Performance:

+6.76%

1M Performance:

+9.41%

6M Performance:

-9.05%

1Y Performance:

+14.51%

1-Day Range:

$2.10

$2.235

1-Week Range:

$2.04

$2.235

52-Week Range:

$1.54

$2.7155

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1175)

Industry

Medical Instruments & Supplies (64)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2025-03-03

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	2.21	183.18M	25.14M	-21.57M	-12.23M	-0.27
ISRG Intuitive Surgical Inc	550.42	197.20B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	168.88	50.02B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	85.14	42.88B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	243.12	36.10B	5.02B	1.31B	1.56B	8.91
BAX Baxter International Inc	29.52	15.84B	11.89B	-560.00M	191.00M	-1.10

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy

View All

Stereotaxis Inc Stock (STXS) Latest News

May 29, 2025

Stereotaxis, Inc. (NYSEAMERICAN:STXS) Stake Raised by Northern Trust Corp - Defense World

May 29, 2025

May 24, 2025

Stereotaxis, Inc. (AMEX:STXS) Q1 2025 Earnings Call Transcript - MSN

May 24, 2025

May 19, 2025

Stereotaxis shareholders approve board nominees and auditor By Investing.com - Investing.com Canada

May 19, 2025

Stereotaxis shareholders approve board nominees and auditor - Investing.com Australia

May 19, 2025

Stereotaxis Holds 2025 Annual Shareholders Meeting - TipRanks

May 19, 2025

May 16, 2025

Stereotaxis reiterates double-digit revenue growth outlook for 2025 as recurring revenue and MAGiC adoption ramp - MSN

May 16, 2025

FY2025 EPS Estimate for Stereotaxis Increased by Analyst - Defense World

May 16, 2025

May 14, 2025

Stereotaxis, Inc. (NYSEAMERICAN:STXS) Stock Position Increased by Wells Fargo & Company MN - Defense World

May 14, 2025